Elisabeth Oelmann
- Immunology top 10%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
- Genetics top 10%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 3
-
- PI3K/AKT/mTOR signaling in cancer 7
-
- Advanced Breast Cancer Therapies 4
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Wolfgang E. BerdelB. ReufiHubert ServeWendy BurkeUdai BanerjiD OberbergHarald SteinHermann Herbst
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Elisabeth Oelmann
29 papers receiving 757 citations
Peers
Comparison fields: 5 of 78
- Immunology 242
- Oncology 268
- Genetics 88
- Pathology and Forensic Medicine 141
- Hematology 83
Countries citing papers authored by Elisabeth Oelmann
This map shows the geographic impact of Elisabeth Oelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Oelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Oelmann more than expected).
Fields of papers citing papers by Elisabeth Oelmann
This network shows the impact of papers produced by Elisabeth Oelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Oelmann. The network helps show where Elisabeth Oelmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Oelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2018 | 3 | |
| 4 | 2017 | 0 | |
| 5 | 2015 | 102 | |
| 6 | 2015 | 13 | |
| 7 | 2012 | 107 | |
| 8 | 2012 | 27 | |
| 9 | 2011 | 17 | |
| 10 | 2005 | 4 | |
| 11 | 2004 | 24 | |
| 12 | 2002 | 4 | |
| 13 | 2002 | 56 | |
| 14 | 2002 | 18 | |
| 15 | 1997 | 42 | |
| 16 | 1995 | 17 | |
| 17 | 1995 | 9 | |
| 18 | 1995 | 27 | |
| 19 | 1994 | 1 | |
| 20 | 1993 | 75 |
About Elisabeth Oelmann
Elisabeth Oelmann is a scholar working on Hematology, Immunology and Oncology, having authored 31 papers that have together received 773 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (7 papers), Immune Cell Function and Interaction (6 papers), Advanced Breast Cancer Therapies (4 papers), Immunotherapy and Immune Responses (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Immunology (242 citations), Oncology (268 citations) and Genetics (88 citations). Elisabeth Oelmann has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Wolfgang E. Berdel, B. Reufi, Hubert Serve, Wendy Burke, Udai Banerji, D Oberberg, Harald Stein, Hermann Herbst, Lynda Grinsted and Éric Raymond. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.